PharmaLCA Software Infographic
This infographic provides an overview of PharmaLCA, highlighting the software's core objective, intended audience and key features.
This infographic provides an overview of PharmaLCA, highlighting the software's core objective, intended audience and key features.
This consolidated Excel workbook provides a standardised framework for collecting production-stage data for PAS 2090-compliant studies. The templates are intended to support both internal LCA activities and engagement with external partners, helping organisations align on data requirements, improve data quality, and make the data gathering and sharing process more efficient. The workbook can be used by any organisation conducting a PAS2090-compliant or aligned study, including pharmaceutical license holders, Contract (Development) Manufacturing Organisations, and raw material suppliers.
The health sector faces growing sustainability demands from regulators, payers, and consumers. A Life Cycle Assessment (LCA) helps quantify environmental impacts across a product’s lifecycle. This training will equip you with foundational LCA knowledge and practical insights for supplier engagement.
A standard, called PAS 2090, aligning practices on LCA for pharmaceutical products was released in Q4 2025. PAS 2090 is used in this training to define specificities of LCA in the sector.
In this training, we will:
The training was published by the Pharmaceutical Supply Chain Initiative (PSCI) and is available via their Learnster platform. Please note you have to register and log in to Learnster before you can access the course.
The Pharma LCA Consortium, supported by its technical advisor Quantis, has developed a technical guidance document to accompany PAS 2090. This guidance aims to facilitate implementation by providing practical recommendations and illustrative examples. Version 1.1 has been issued to address identified discrepancies with PAS 2090, notably in relation to table referencing, and to improve overall clarity and alignment.
A joint publication by the International Federation of Pharmaceutical Wholesalers and the Pharmaceutical Environment Group to align on GHG reporting and data sharing approaches between pharmaceutical companies and wholesalers.
This infographic provides a visual overview of PAS 2090, outlining the standard's development process, core principles, intended audience and the key lifecycle stages it addresses.
This FAQ document is tailored for pharmaceutical suppliers and addresses common questions about PAS 2090, Life Cycle Assessments, available datasets and tools, and other practical considerations for implementation.
This abstract describes the initial steps in an overarching programme to improve the measurement and reporting of environmental information for medicines. The technical work described is a key foundational element that will lead to the development of a universal, consensus-led standard for the benefit of the global healthcare systems, in its many forms, and ultimately for the improved health of patients and the environment in which they live.